Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
US OTC Drug Industry’s Input On PDUFA Reauthorization Emphasizes Switch NDA Output
Jan 14 2026
•
By
Malcolm Spicer
(Source: Shutterstock/Citeline)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Rx-to-OTC Switch
More from Health